Botulinum toxin treatment for limb spasticity in childhood cerebral palsy

Vito Pavone, Gianluca Testa, Domenico A. Restivo, Luca Cannavò, Giuseppe Condorelli, Nicola M. Portinaro, Giuseppe Sessa

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

CP is the most common cause of chronic disability in childhood occurring in 2-2.5/1000 births. It is a severe disorder and a significant number of patients present cognitive delay and difficulty in walking. The use of botulinum toxin (BTX) has become a popular treatment for CP especially for spastic and dystonic muscles while avoiding deformity and pain. Moreover, the combination of physiotherapy, casting, orthotics and injection of BTX may delay or decrease the need for surgical intervention while reserving single-event, multi-level surgery for fixed musculotendinous contractures and bony deformities in older children. This report highlights the utility of BTX in the treatment of cerebral palsy in children. We include techniques for administration, side effects, and possible resistance as well as specific use in the upper and lower limbs muscles.

Original languageEnglish
Article number29
JournalFrontiers in Pharmacology
Volume7
Issue numberFEB
DOIs
Publication statusPublished - Feb 19 2016

Fingerprint

Botulinum Toxins
Cerebral Palsy
Extremities
Mobility Limitation
Muscles
Muscle Spasticity
Contracture
Lower Extremity
Therapeutics
Parturition
Pain
Injections

Keywords

  • Botulinum toxin A
  • Cerebral palsy
  • Key-muscle
  • Multi-level treatment
  • Resistance

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Pavone, V., Testa, G., Restivo, D. A., Cannavò, L., Condorelli, G., Portinaro, N. M., & Sessa, G. (2016). Botulinum toxin treatment for limb spasticity in childhood cerebral palsy. Frontiers in Pharmacology, 7(FEB), [29]. https://doi.org/10.3389/fphar.2016.00029

Botulinum toxin treatment for limb spasticity in childhood cerebral palsy. / Pavone, Vito; Testa, Gianluca; Restivo, Domenico A.; Cannavò, Luca; Condorelli, Giuseppe; Portinaro, Nicola M.; Sessa, Giuseppe.

In: Frontiers in Pharmacology, Vol. 7, No. FEB, 29, 19.02.2016.

Research output: Contribution to journalArticle

Pavone, V, Testa, G, Restivo, DA, Cannavò, L, Condorelli, G, Portinaro, NM & Sessa, G 2016, 'Botulinum toxin treatment for limb spasticity in childhood cerebral palsy', Frontiers in Pharmacology, vol. 7, no. FEB, 29. https://doi.org/10.3389/fphar.2016.00029
Pavone, Vito ; Testa, Gianluca ; Restivo, Domenico A. ; Cannavò, Luca ; Condorelli, Giuseppe ; Portinaro, Nicola M. ; Sessa, Giuseppe. / Botulinum toxin treatment for limb spasticity in childhood cerebral palsy. In: Frontiers in Pharmacology. 2016 ; Vol. 7, No. FEB.
@article{ce64315cc83d4e0e957adfec2ae7d433,
title = "Botulinum toxin treatment for limb spasticity in childhood cerebral palsy",
abstract = "CP is the most common cause of chronic disability in childhood occurring in 2-2.5/1000 births. It is a severe disorder and a significant number of patients present cognitive delay and difficulty in walking. The use of botulinum toxin (BTX) has become a popular treatment for CP especially for spastic and dystonic muscles while avoiding deformity and pain. Moreover, the combination of physiotherapy, casting, orthotics and injection of BTX may delay or decrease the need for surgical intervention while reserving single-event, multi-level surgery for fixed musculotendinous contractures and bony deformities in older children. This report highlights the utility of BTX in the treatment of cerebral palsy in children. We include techniques for administration, side effects, and possible resistance as well as specific use in the upper and lower limbs muscles.",
keywords = "Botulinum toxin A, Cerebral palsy, Key-muscle, Multi-level treatment, Resistance",
author = "Vito Pavone and Gianluca Testa and Restivo, {Domenico A.} and Luca Cannav{\`o} and Giuseppe Condorelli and Portinaro, {Nicola M.} and Giuseppe Sessa",
year = "2016",
month = "2",
day = "19",
doi = "10.3389/fphar.2016.00029",
language = "English",
volume = "7",
journal = "Frontiers in Pharmacology",
issn = "1663-9812",
publisher = "Frontiers Media S.A.",
number = "FEB",

}

TY - JOUR

T1 - Botulinum toxin treatment for limb spasticity in childhood cerebral palsy

AU - Pavone, Vito

AU - Testa, Gianluca

AU - Restivo, Domenico A.

AU - Cannavò, Luca

AU - Condorelli, Giuseppe

AU - Portinaro, Nicola M.

AU - Sessa, Giuseppe

PY - 2016/2/19

Y1 - 2016/2/19

N2 - CP is the most common cause of chronic disability in childhood occurring in 2-2.5/1000 births. It is a severe disorder and a significant number of patients present cognitive delay and difficulty in walking. The use of botulinum toxin (BTX) has become a popular treatment for CP especially for spastic and dystonic muscles while avoiding deformity and pain. Moreover, the combination of physiotherapy, casting, orthotics and injection of BTX may delay or decrease the need for surgical intervention while reserving single-event, multi-level surgery for fixed musculotendinous contractures and bony deformities in older children. This report highlights the utility of BTX in the treatment of cerebral palsy in children. We include techniques for administration, side effects, and possible resistance as well as specific use in the upper and lower limbs muscles.

AB - CP is the most common cause of chronic disability in childhood occurring in 2-2.5/1000 births. It is a severe disorder and a significant number of patients present cognitive delay and difficulty in walking. The use of botulinum toxin (BTX) has become a popular treatment for CP especially for spastic and dystonic muscles while avoiding deformity and pain. Moreover, the combination of physiotherapy, casting, orthotics and injection of BTX may delay or decrease the need for surgical intervention while reserving single-event, multi-level surgery for fixed musculotendinous contractures and bony deformities in older children. This report highlights the utility of BTX in the treatment of cerebral palsy in children. We include techniques for administration, side effects, and possible resistance as well as specific use in the upper and lower limbs muscles.

KW - Botulinum toxin A

KW - Cerebral palsy

KW - Key-muscle

KW - Multi-level treatment

KW - Resistance

UR - http://www.scopus.com/inward/record.url?scp=84962018639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962018639&partnerID=8YFLogxK

U2 - 10.3389/fphar.2016.00029

DO - 10.3389/fphar.2016.00029

M3 - Article

AN - SCOPUS:84962018639

VL - 7

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

IS - FEB

M1 - 29

ER -